News | FFR Technologies | January 04, 2022

European Trial Evaluates Angiography Vessel Fractional Flow Reserve (vFFR) Guided PCI Versus Conventional FFR

Pie Medical Imaging CAAS vFFR non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III trial

The Pie Medical Imaging angiography-based vessel fractional flow reserve (CAAS vFFR) technology can use angiography imaging alone to assess FFR without the need for pressure wires or  adenosine.

The Pie Medical Imaging angiography-based vessel fractional flow reserve (CAAS vFFR) technology can use angiography imaging alone to assess FFR without the need for pressure wires or adenosine.


January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently announced the beginning of FASTIII, a multicenter randomized clinical trial investigating the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in patients undergoing coronary revascularization procedures.  

The FASTIII trial is led by Dr. Joost Daemen, cardiologist at the Thoraxcenter at the Erasmus University Medical Center, Rotterdam, The Netherlands. It is an investigator initiated international, multi-center randomized, non-inferiority trial aiming to enroll a total of 2228 patients, in seven European countries and 35 hospitals and is sponsored by the European Cardiovascular Research Institute (ECRI)

The FAST III study aims to demonstrate non-inferiority of CAAS vFFR guided revascularization as compared to a conventional invasive wire based FFR guided revascularization in patients with either stable coronary syndrome or non-ST segment elevation myocardial infarction and intermediate coronary artery lesions.  

vFFR can assess whether a coronary artery narrowing is functionally severe and requires treatment. CAAS vFFR allows doing so without the need for adenosine or invasive wires that are part of the routine practice to measure FFR pressure gradients.

The high diagnostic accuracy of CAAS vFFR, which calculates pressure drop and vFFR value using angiography images only was recently confirmed by the results of FAST I, FAST Extend and FASTII studies which validated vFFR as an accurate and easy to use tool to assess coronary physiology. 

“We are confident that this new study will lead to a broader use of methods based on angiographic images for a safe and accurate assessment of severity and percentage of artery stenosis” said René Guillaume, PMI managing director. 

The trial is funded by research grants from Pie Medical Imaging (Maastricht, the Netherlands) and Siemens Healthineers GmbH (Erlangen, Germany). 

For more information: www.piemedicalimaging.com 

 

Related Image-based FFR Technology Content:

Image-based FFR May Replace Pressure Wires and Adenosine

7 Trends in Interventional Lab Angiography Systems

New Technology Directions in Fractional Flow Reserve (FFR)

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
 

Related Content

Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
News | Cath Lab

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
Subscribe Now